Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations.

MLA

Ross, Jeffrey S., et al. “Relapsed Classic E-Cadherin (CDH1)-Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 19, no. 10, May 2013, pp. 2668–76. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-13-0295.

APA

Ross, J. S., Wang, K., Sheehan, C. E., Boguniewicz, A. B., Otto, G., Downing, S. R., Sun, J., He, J., Curran, J. A., Ali, S., Yelensky, R., Lipson, D., Palmer, G., Miller, V. A., & Stephens, P. J. (2013). Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 19(10), 2668–2676. https://doi.org/10.1158/1078-0432.CCR-13-0295

Chicago

Ross, Jeffrey S, Kai Wang, Christine E Sheehan, Ann B Boguniewicz, Geoff Otto, Sean R Downing, James Sun, et al. 2013. “Relapsed Classic E-Cadherin (CDH1)-Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 19 (10): 2668–76. doi:10.1158/1078-0432.CCR-13-0295.